Missouri Trust & Investment Company’s AbbVie ABBV Stock Holding History

Missouri Trust & Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Sell	7,082 -75	-1%	-$16.1K	0.48%	48
2026 Q1	$1.56M	Buy	7,157 +35	+0.5%	+$7.76K	0.46%	53
2025 Q4	$1.63M	Sell	7,122 -4	-0.1%	-$911	0.48%	47
2025 Q3	$1.65M	Buy	7,126 +20	+0.3%	+$4.07K	0.49%	43
2025 Q2	$1.32M	Buy	7,106 +1	+0%	+$186	0.43%	52
2025 Q1	$1.49M	Sell	7,105 -50	-0.7%	-$9.72K	0.52%	39
2024 Q4	$1.27M	Buy	7,155 +26	+0.4%	+$4.78K	0.45%	47
2024 Q3	$1.41M	Sell	7,129 -19	-0.3%	-$3.55K	0.49%	45
2024 Q2	$1.23M	Sell	7,148 -74	-1%	-$12.3K	0.46%	50
2024 Q1	$1.32M	Buy	7,222 +508	+8%	+$87.5K	0.51%	45
2023 Q4	$1.04M	Sell	6,714 -9	-0.1%	-$1.31K	0.42%	53
2023 Q3	$1M	Hold	6,723	–	–	0.45%	44
2023 Q2	$906K	Buy	6,723 +683	+11%	+$100K	0.51%	48
2023 Q1	$963K	Sell	6,040 -390	-6%	-$59.6K	0.62%	40
2022 Q4	$1.04M	Buy	6,430 +860	+15%	+$132K	0.62%	37
2022 Q3	$748K	Buy	5,570 +945	+20%	+$136K	0.49%	45
2022 Q2	$708K	Sell	4,625 -25	-0.5%	-$3.82K	0.46%	53
2022 Q1	$754K	Buy	4,650 +64	+1%	+$9.3K	0.44%	55
2021 Q4	$621K	Buy	+4,586	New	+$542K	0.36%	64

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Missouri Trust & Investment Company's ABBV Position: Q2 2026 in Review

Missouri Trust & Investment Company reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $16.1K and leaving 7,082 shares worth $1.78M. The position accounts for 0.48% of the portfolio, ranked #48.

Missouri Trust & Investment Company first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Missouri Trust & Investment Company held 7,082 shares of AbbVie worth $1.78M as of Q2 2026.
Missouri Trust & Investment Company sold 75 AbbVie shares in Q2 2026, an estimated $16.1K.
AbbVie made up 0.48% of Missouri Trust & Investment Company's portfolio in Q2 2026, its #48 holding.
Missouri Trust & Investment Company first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.